In this article/podcast from KevinMD.com, a nephrologist discusses being terminated after 15 years at the same institution as a physician in a private practice multi-specialty clinic. Despite getting employees to focus on accountability and rally behind organizational goals – not to mention the ongoing challenges of dealing with COVID-19 – the physician was fired. Was it warranted? Read on to decide for yourself.

Although both acetaminophen and ibuprofen are commonly used for pain relief and fever reduction in children, recommendations for their use in this population are inconsistent, according to the researchers, whose study results were published in JAMA. Of the 241,138 participants over 19 studies, which treatment showed more promise in fever and pain reduction?

Olaparib, a PARP inhibitor, is approved for the treatment of human epidermal growth factor receptor 2 (HER2)–negative metastatic breast cancer (MBC) in germline (g)BRCA1/2 mutation carriers. Find out whether the results from this latest report will emphasize the value of molecular characterization (homologous recombination (HR)–related genes other than BRCA1/2) for treatment decisions in MBC.

Are traditional cytotoxic chemotherapies becoming a thing of the past? This study in the Journal of Clinical Oncology shows a move toward targeted agents, as a combination of obinutuzumab, ibrutinib, and venetoclax induced deep remissions in patients with treatment-naive or relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

We all have the same number of hours in the day. Things need to get done, and when you’re a physician, sometimes the day is gone before you feel like you even got started. Here are some tips and tricks to help streamline your schedule and improve your time management. You, your staff, and your family will appreciate the productivity and efficiency gains these tips could offer.

In this symposium preceding the ASH Annual Meeting on 12/4/20, the overall objective is to inform participants about emerging diagnostic and therapeutic aspects of bleeding and thrombotic disorders. The speakers will illustrate how costly and unnecessary biochemical, phenotypic, and genetic testing can be avoided in the participants’ practices while enhancing highest quality medical care.